Literature DB >> 11239860

Glycemic control and lens transparency in patients with type 1 diabetes mellitus.

S Kato1, A Shiokawa, H Fukushima, J Numaga, S Kitano, S Hori, T Kaiya, T Oshika.   

Abstract

PURPOSE: To assess quantitatively the cumulative effect of hyperglycemia on lens transparency in patients with juvenile type 1 diabetes mellitus.
METHODS: Subjects were 30 patients (30 eyes) with type 1 diabetes mellitus who had well-documented records on the duration of diabetes mellitus and condition of glycemic control from the onset. They were 35 years of age or younger (mean, 26.0 years), had a history of type 1 diabetes mellitus at least 5 years (mean, 8.4 years), had corrected visual acuity of 20/20 or better, and showed no clinically apparent cataract on slit-lamp examination. Twenty-one eyes of 21 subjects served as age-matched normal controls. They were 35 years of age or younger (mean, 25.7 years), had no diabetes mellitus, had corrected visual acuity of 20/20 or better, and showed no signs of cataract on slit-lamp examination. The degree of lens opacity was quantified using the anterior eye segment analysis system based on the Scheimpflug principle. An index was created to represent the cumulative effect of long-term glycemic control (hyperglycemic accumulation) by multiplying the average hemoglobin A(1c) value and the number of months from the onset.
RESULTS: The patients with diabetes mellitus exhibited significantly greater degree of lens opacity than the normal controls (P =.017, Mann-Whitney U-test). Among the patients with diabetes mellitus, the lens opacity was greater in eyes with retinopathy than those without retinopathy (P =.011). Multiple regression analysis revealed that only the index of hyperglycemic accumulation significantly correlated with the degree of lens opacity (P =.042).
CONCLUSION: Accumulated effect of hyperglycemia is related to the lens transparency in patients with diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239860     DOI: 10.1016/s0002-9394(00)00804-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  ‏Impact of Food Habits on Cataract Development Among Adults in Aseer Region, Saudi Arabia: A Retrospective Study.

Authors:  Waleed Aldhabaan; Ahmed S Al-Zomia; Lama A Lahiq; Mushary Alqahtani; Shuruq Al-Qahtani; Sulafah Aljohani; Tariq Al-Mufarrih; Yazeed S Alshahrani
Journal:  Cureus       Date:  2022-05-10

2.  Wavefront error correction with adaptive optics in diabetic retinopathy.

Authors:  Ali Kord Valeshabad; Justin Wanek; Patricia Grant; Jennifer I Lim; Felix Y Chau; Ruth Zelkha; Nicole Camardo; Mahnaz Shahidi
Journal:  Optom Vis Sci       Date:  2014-10       Impact factor: 1.973

3.  Dietary glycemic index, glycemic load and risk of age-related cataract extraction: a case-control study in Italy.

Authors:  Federica Turati; Maria Filomeno; Carlotta Galeone; Diego Serraino; Ettore Bidoli; Carlo La Vecchia
Journal:  Eur J Nutr       Date:  2014-07-14       Impact factor: 5.614

Review 4.  Ocular associations of diabetes other than diabetic retinopathy.

Authors:  V Swetha E Jeganathan; Jie Jin Wang; Tien Yin Wong
Journal:  Diabetes Care       Date:  2008-09       Impact factor: 19.112

5.  Association study between superoxide Dismutases gene polymorphisms and development of diabetic retinopathy and cataract in Iranian patients with type two diabetes mellitus.

Authors:  Leila Saremi; Somayye Taghvaei; Fatemeh Feizy; Mohammad Ebrahim Ghaffari; Sepideh Babaniamansour; Zohreh Saltanatpour
Journal:  J Diabetes Metab Disord       Date:  2021-04-04

6.  Cataracts in diabetic patients: a review article.

Authors:  Mohammad-Ali Javadi; Siamak Zarei-Ghanavati
Journal:  J Ophthalmic Vis Res       Date:  2008-01

7.  Short-term stability in refractive status despite large fluctuations in glucose levels in diabetes mellitus type 1 and 2.

Authors:  Byki Huntjens; W Neil Charman; Helena Workman; Sarah L Hosking; Clare O'Donnell
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.